Farren C K, O'Malley S, Grebski G, Maniar S, Porter M, Kreek M J
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06511, USA.
Alcohol Clin Exp Res. 1999 Mar;23(3):502-8.
Opiate antagonists have been found to stimulate the hypothalamic-pituitary-adrenal axis. However, despite established usefulness in the management of alcoholism, systematic, oral dose-titrated natrexone-induced hypothalamic-pituitary-adrenal stimulation has never been studied in alcoholics. Six patients (5 males, 1 female) with DSM-IV alcohol dependence, who were at least 4 weeks abstinent from any alcohol [mean 55 days (+/-SE 7.5)], were given four challenges of oral naltrexone (0, 25, 50, and 100 mg) in a randomized order at least 3 days apart, after an overnight fast. Naltrexone was administered at 9 AM; serum ACTH, cortisol, and prolactin were measured at time 0 and at 9 time points over the next 4 hr. Subjects also filled out a side effect questionnaire and an alcohol urge questionnaire. Physiological measurements of blood pressure and pulse rate were taken at the same time points. Repeated-measures ANOVA of the changes in serum ACTHs over time revealed a significant effect of drug (placebo vs. any dose of naltrexone) (p < 0.05). Post-hoc analysis revealed a significant difference between placebo and the 25 mg dose (p < 0.01), the 50 mg dose (p < 0.01), but no significance between the placebo and the 100 mg dose (p = 0.1). A repeated-measures ANOVA of the changes in serum cortisols over time revealed a significant effect of drug (p < 0.01). Post-hoc analysis revealed a significant difference between placebo and the 25 mg dose (p < 0.01), between placebo and the 50 mg dose (p < 0.05), and placebo and the 100 mg dose (p < 0.01). There was a significant between dose difference in pulse rate changes over baseline (p < 0.01), and post-hoc analysis revealed a significant diminution in pulse rate at the 100 mg dose relative to placebo (p < 0.001), and to the other doses. There were no significant differences in reported side effects, alcohol urge questionnaire scores, or in other physiological measurements between doses. These data suggest a significant rise in ACTH and cortisol in response to naltrexone in alcoholics compared with placebo, with no differences between 25 mg, 50 mg, and 100 mg doses, and a significant diminution in pulse rate responses at the 100 mg dose.
已发现阿片类拮抗剂可刺激下丘脑 - 垂体 - 肾上腺轴。然而,尽管纳曲酮在酒精中毒管理方面已证实有效,但系统的、口服剂量滴定的纳曲酮诱导的下丘脑 - 垂体 - 肾上腺刺激在酗酒者中从未被研究过。六名符合DSM - IV酒精依赖标准的患者(5名男性,1名女性),已至少4周未饮酒(平均55天(±标准误7.5)),在禁食过夜后,以随机顺序,至少间隔3天接受四次口服纳曲酮(0、25、50和100毫克)挑战。纳曲酮于上午9点给药;在给药前(时间0)以及接下来4小时内的9个时间点测量血清促肾上腺皮质激素(ACTH)、皮质醇和催乳素。受试者还填写了一份副作用问卷和一份酒精渴望问卷。在相同时间点测量血压和脉搏率的生理指标。对血清ACTH随时间变化进行重复测量方差分析显示药物有显著作用(安慰剂与任何剂量的纳曲酮相比)(p < 0.05)。事后分析显示安慰剂与25毫克剂量之间有显著差异(p < 0.01),与50毫克剂量之间有显著差异(p < 0.01),但安慰剂与100毫克剂量之间无显著差异(p = 0.1)。对血清皮质醇随时间变化进行重复测量方差分析显示药物有显著作用(p < 0.01)。事后分析显示安慰剂与2